increasingly used for moderate-to-severe CD Antibiotics: Metronidazole, ciprofloxacin for perianal disease, fistulae, abscesses Coding Impact of Biologic Therapy When a patient is receiving biologic therapy for Crohns disease, coders should verify: HCPCS code for the specific biologic agent (J1745, J3357, J3380, J7999) is separately reported for the infusion encounter Infusion administration code (CPT 96413, 96415) is reported with the biologic J-code Long-term use of immunosuppressants should be captured with Z79.899 (long-term use of other medication) when relevant Biologic use combined with Crohns disease supports HCC 35 mapping and higher risk scores When corticosteroid use (prednisone, budesonide) extends beyond 90 days, assign Z79.52 (long-term use of systemic steroids)
A Certificate of Analysis (COA) is published on the product page and independently verifiable at verify.janoshik.com using the batch reference number
10.1111/mmi.15366 107 MautheM.KampingaH.ReggioriF
Not a generic dose pulled off a shelf
Most individuals find 0.1 to 0.15 mg daily sufficient for chronic condition management
This standard helps avoid mistakes when giving the shots
